Garwood Medical Devices, LLC announced that it has received funding from Teijin Limited, Pegasus Tech Ventures, Inc.

Teijin Limited is a diversified group organized around 5 areas of activity: - manufacturing and distribution of textile products and clothes (37.6% of net sales): textile fibers, polyesters, polymers, etc.; - production of synthetic fibers (35.5%): aramid, carbon and polyester fibers for industrial applications; - manufacturing of care and health products (17.8%): medicines (for the treatment of metabolic, cardiovascular, bone, joint and respiratory diseases), and home care equipments (home oxygen therapy equipments and positive pressure fans); - sale of IT products and services (6.9%); - other (2.2%). Net sales break down geographically as follows: Japan (58.6%), China (13.1%), Asia (6.9%), Americas (13.7%) and other (7.7%).